食品伙伴網(wǎng)訊  據(jù)歐盟網(wǎng)站消息，6月16日歐盟委員會及其新興鑒定健康風險科學委員會（SCENIHR） 發(fā)布銀納米顆粒對安全、健康和環(huán)境影響以及耐藥性作用的最終意見。

    該意見旨在評估與傳統(tǒng)銀相比，納米銀的使用與是否會導致額外的風險，尤其是在醫(yī)療保健和消費品中。以及納米銀用于控制細菌生長時，是否會導致微生物的耐藥性。

    歐盟委員會稱，考慮到銀納米粒子在使用時可能產(chǎn)生的耐藥性問題，因此有必要獲取更多的有關病菌對陰離子與銀納米粒子反應的數(shù)據(jù)。

    部分原文報道如下：

    Today, the European Commission and its non-food Scientific Committee on Emerging and Newly Identified Health Risks, SCENIHR, published the final opinion on “Nanosilver: safety, health and environmental effects and role in antimicrobial resistance”.

    The aim of this opinion is to assess whether the use of nanosilver, in particular in medical care and in consumer products, could result in additional risks compared to more traditional uses of silver and whether the use of nanosilver to control bacterial growth could result in resistance of micro-organisms.

    Regarding the hazard associated with the dissemination of the resistance mechanism following the use of silver nanoparticles, more data are needed to better understand bacterial response to ionic silver and silver nanoparticles exposure.

    原文鏈接：http://ec.europa.eu/dgs/health_consumer/dyna/enews/enews.cfm?al_id=1494